MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Single-photon emission computed tomography(SPECT)"

  • 2023 International Congress

    Education and the motor effects of dopamine loss in Parkinson’s disease

    M. Hoenig, V. Dzialas, M. Banwinkler, A. Asendorf, T. van Eimeren (Juelich, Germany)

    Objective: To examine the relation between education and dopamine signal loss in PD. Background: In support of the cognitive reserve concept, it has consistently been…
  • 2023 International Congress

    Artificial intelligence for the improvement of imaging biomarkers in Parkinson’s disease

    V. Dzialas, E. Doering, K. Simonyan, A. Strafella, D. Vaillancourt, T. van Eimeren (Cologne, Germany)

    Objective: To systematically review the current literature on the application of artificial intelligence (AI) for imaging biomarkers in Parkinson's disease (PD) and to identify translational…
  • 2023 International Congress

    Network attack tolerance: A resilience proxy for Parkinson’s disease?

    A. Asendorf, A. Temizyürek, M. Banwinkler, V. Dzialas, THE. Parkinson-Progression-Marker-Initiative, T. van Eimeren, M. Hoenig (Cologne, Germany)

    Objective: To investigate if individual capacity in network attack tolerance moderates the relationship between striatal dopamine loss and symptom severity in PD. Background: It was…
  • 2023 International Congress

    Diabetes impact on nigrostriatal vulnerability in Parkinson’s Disease

    A. Galli, A. Pilotto, C. Zatti, C. Tirloni, A. Lupini, B. Paghera, A. Padovani (Brescia, Italy)

    Objective: aim of the study was to investigate whether diabetes mellitus influences nigrostriatal dopaminergic vulnerability in drug-naïve patients with early-stage Parkinson’s Disease (PD). Background: recently,…
  • 2023 International Congress

    A 20-Year Follow-Up Case Report with Three DaT-SPECT Scans in Parkinson’s Disease Diagnosis

    S. Virameteekul, K. Bhatia (London, United Kingdom)

    Objective: To describe a patient who underwent multiple DAT-SPECT scans over a 20-year clinical follow-up period in three distinct clinical settings: a normal scan excluding…
  • 2023 International Congress

    Rest Tremor in Parkinson’s Disease Is Associated with Increased Ipsilateral DAT Binding

    K. Niemi, J. Sunikka, V. Kaasinen, J. Joutsa (Turku, Finland)

    Objective: To investigate the connection between striatal dopamine transporter binding and cardinal motor symptoms of Parkinson’s disease. Background: The three cardinal motor symptoms of Parkinson’s…
  • 2023 International Congress

    Increased free water in the putamen in idiopathic REM sleep behaviour disorder

    D. Zhang, L. Zhou, J. Liu, T. Wu (Beijing, China)

    Objective: This study aimed to evaluate the free water in the dorsoposterior putamen of idiopathic REM sleep behaviour disorder (iRBD) patients, which is considered a…
  • 2023 International Congress

    Hemiparkinsonism secondary to a cerebral cavernous malformation (CCM)

    M. González Sánchez, B. De-La-Casa Fages, JR. Pérez Sánchez, A. Contreras Chicote, S. Secades García, E. Luque Buzo, Y. Fernández Bullido, G. Lafuente Gómez, O. Mateo Sierra, FJ. Grandas Pérez (Madrid, Spain)

    Objective: To describe a case of secondary parkinsonism of unhabitual cause and complex treatment. Background: Secondary parkinsonism constitutes approximately 15% of all parkinsonism cases in…
  • 2023 International Congress

    Neurophysiological markers of motor reserve in Parkinson’s disease

    M. Passaretti, S. Rinaldo, E. Orunesu, D. Rossi Sebastiano, G. de Vigili, G. Barbiera, A. Braccia, G. Paparella, M. de Riggi, P. Lanteri, A. Berardelli, A P. Strafella, M. Bologna, R. Eleopra, R. Cilia (Rome, Italy)

    Objective: Our objective was to investigate Motor Reserve (MR) in idiopathic Parkinson’s Disease (PD). Background: MR is defined as the resilience mechanisms of the brain…
  • 2022 International Congress

    Investigating the use of DAT-SPECT as an enrichment biomarker to determine eligibility for the phase 2 clinical trial PASADENA

    T. Kustermann, S. Holiga, S. Zanigni, H. Svoboda, T. Nikolcheva, G. Pagano, K. Taylor (Basel, Switzerland)

    Objective: Evaluate dopaminergic imaging DAT-SPECT as an enrichment strategy to avoid inclusion of participants with scans without evidence of dopaminergic deficit (SWEDD) in a Phase…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 16
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley